Archive · 13 Dec 2025
Ozempic Launched in India for Diabetes
Novo Nordisk, a Danish pharmaceutical company, has launched a medicine called Ozempic in India.
Ozempic is used to treat type 2 diabetes and can also help with weight loss.
It comes in three different doses and costs Rs 8,800 per month for the lowest dose.
The company says the price is competitive and affordable.
Ozempic is approved only for diabetes treatment in India.
Novo Nordisk is responsible for distributing Ozempic.
India has a large number of people with diabetes, prediabetes, and obesity, making this medicine important for many.
Doctors warn that Ozempic should not be used just for weight loss without medical supervision.
The drug's patent is set to expire next year, which could lead to cheaper generic versions.
Ozempic, a type 2 diabetes treatment, launched in India by Novo Nordisk.
Available in 0.25 mg, 0.5 mg, and 1 mg doses at Rs 8,800, Rs 10,170, and Rs 11,175 per month respectively.
Marketed purely for type 2 diabetes treatment in India.
Novo Nordisk ensures uninterrupted supply and competitive pricing.
India has 101 million people with diabetes, 136 million with prediabetes, and 254 million with obesity.
- Who
- Novo Nordisk
- What
- Launched Ozempic for type 2 diabetes treatment in India
- When
- Friday, December 12, 2025
- Where
- India
- Why
- To provide innovative and accessible therapy for type 2 diabetes and weight management
- Company
- Novo Nordisk
- Product
- Ozempic (injectable semaglutide)
- Pricing
- Rs 8,800 per month (0.25 mg), Rs 10,170 per month (0.5 mg), Rs 11,175 per month (1 mg)
- Dosage
- 0.25 mg, 0.5 mg, 1 mg
- Approval
- Type 2 diabetes treatment
- Market
- India
- Diabetes Population in India
- 101 million
- Prediabetes Population in India
- 136 million
- Obesity Population in India
- 254 million
- Patent Expiry
- March 2025
- Competitor
- Eli Lilly's Mounjaro
- Generic Versions
- Expected to be 80% cheaper
- Anti-Obesity Drugs in Pipeline
- More than 14
Sources
Ozempic launched in India, priced at Rs 2,200 per week
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
Weight-loss drug Ozempic launched in India, priced at Rs 8,800 a month
Novo Nordisk launches blockbuster drug Ozempic in India for diabetes and weight loss
Ozempic Too Costly? 7 Cheaper And Clinically Approved Alternatives Available In India
Ozempic adds to India’s growing appetite for anti-obesity drugs
Ozempic launch & beyond: Weight-loss matters, say doctors while appetite builds for generics-led price cuts
Ozempic launched in India, priced at Rs 2,200 per week
'14+ Anti-Obesity Drugs In The Pipeline'
As Ozempic launches in India, experts suggest caution, list considerations: ‘This is not a shortcut solution’
Ozempic pricing explained: Novo Nordisk India Head says, ‘we’ll drive science and stay competitive’
